172 results match your criteria: "Center for Regulatory Science[Affiliation]"

Recent discussions about the utilization of real-world data (RWD) and real-world evidence (RWE) have been more focused on drug development for regulatory approval rather than during the post-marketing stage. In Japan, RWD/RWE have been practically utilized as an external control for drug approval. Most cases were related to orphan diseases where the feasibility of conducting randomized controlled clinical trials was generally low.

View Article and Find Full Text PDF

Chimeric antigen receptor T (CAR T) cell therapies have emerged as a valuable treatment modality for patients with plasma cell disorders. As the population of patients receiving CAR T therapies grows, the identification and management of associated rare toxicities become increasingly crucial. This study aims to identify safety signals associated with commercial anti-B-cell maturation antigen (BCMA) CAR T therapies using the Food and Drug Administration Adverse Event Reporting System (FAERS).

View Article and Find Full Text PDF

Mapping the Clinical Development Trajectory of Cell and Gene Therapy Products.

Clin Pharmacol Ther

December 2024

Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.

Article Synopsis
  • Cell and gene therapies (CGTs) have shown potential for treating hard-to-treat conditions, but their development is risky for pharmaceutical companies due to uncertainties in clinical trials and regulatory approval.
  • An analysis of CGT products from 1993 to 2023 found that only 5.3% received regulatory approval, with higher chances for products with orphan designation and lower chances for oncology-related therapies.
  • Both CAR T cell therapies and AAV gene therapies showed a similar approval likelihood of 13.6%, highlighting that approval rates vary by product type and therapeutic indication.
View Article and Find Full Text PDF

Risk of artery dissection during systemic exposure to vascular endothelial growth factor pathway inhibitors.

Clin Transl Sci

December 2024

Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.

Whether or not vascular endothelial growth factor pathway inhibitors (VPIs) increase the risk of artery dissection is still unknown. This study aimed to quantitatively evaluate the possibility of artery dissection as a class effect of VPIs using nationwide real-world data. This cohort study was conducted based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB), which spans nearly the entire Japanese population of over 100 million individuals.

View Article and Find Full Text PDF

Introduction: Understanding the metastatic patterns is crucial for the treatment of malignancies. This study aimed to identify the characteristic organ metastases of primary malignancies, including rare malignancies, and classify them according to their metastatic patterns.

Methods: We extracted data on primary malignancies and organ metastases from the Annual of Pathological Autopsy Cases in Japan recorded in 1993-2021.

View Article and Find Full Text PDF

Purpose: Health care providers (HCP) are uniquely positioned to advise against electronic cigarette (e-cigarette) use, potentially influencing youth perceptions of e-cigarette harms. However, research examining these associations is scant. We examined whether HCP e-cigarette-related advice is associated with youth e-cigarette harm perceptions.

View Article and Find Full Text PDF

An almost infinite sites model.

Theor Popul Biol

December 2024

Department of Statistics, University of Oxford, 24-29 St Giles', Oxford OX1 3LB, United Kingdom. Electronic address:

Motivation: A main challenge in molecular evolution is to find computationally efficient mutation models with flexible assumptions that properly reflect genetic variation. The infinite sites model assumes that each mutation event occurs at a site never previously mutant, i.e.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to evaluate the safety of COVID-19 treatments nirmatrelvir/ritonavir (NMVr) and molnupiravir (MOL) by comparing acute complications in treated versus untreated patients.
  • Data from nationwide databases were used to analyze results from over 700,000 NMVr users and over 150,000 MOL users, focusing on specific cardiac and neurological events.
  • The findings revealed that both NMVr and MOL users had a lower risk of certain serious side effects like atrial fibrillation and dysgeusia, suggesting these treatments may be effective in reducing acute complications linked to COVID-19.
View Article and Find Full Text PDF

Understanding the association between initial experimentation with a tobacco product and subsequent patterns of tobacco use among youth is important to informing prevention activities for youth in the US. We conducted an online survey from August to October 2017 among youth aged 13-18 years. The current analysis focused on respondents reporting initial experimentation with any tobacco product (n = 2,022).

View Article and Find Full Text PDF

Introduction: Anti-tumor necrosis factor (anti-TNF) therapy may improve insulin sensitivity, and its impact during pregnancy remains unclear. We aimed to assess the risk of gestational diabetes mellitus (GDM) associated with anti-TNF treatment among pregnant women with inflammatory bowel disease (IBD).

Methods: This nationwide cohort study included patients with IBD in Korea from 2010 to 2021.

View Article and Find Full Text PDF

The challenges of regulatory pluralism.

Health Policy

November 2024

KPM Center for Public Management, University of Bern, Freiburgstr. 3, 3010 Bern, Switzerland; Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel), Freiburgstr. 3, 3010 Bern, Switzerland.

Countries with small and/or less-resourced regulatory authorities that operate outside of a larger medical product regulatory system face a regulatory strategy dilemma. These countries may rely on foreign well-resourced regulators by recognising the regulatory decisions of large systems and following suit (regulatory reliance); alternatively, such countries may extend formal decision recognition to regulators in multiple other jurisdictions with similar oversight and public health goals, following a system which we call regulatory pluralism. In this policy comment, we discuss three potential limitations to regulatory pluralism: (i) regulatory escape, in which manufacturers exploit regulatory variation and choose the lowest regulatory threshold for their product; (ii) increased fragmentation and complexity for countries adopting this approach, which may, in turn, lead to inconsistent processes; and (iii) loss of international bargaining power in developing regulatory policies.

View Article and Find Full Text PDF

Biosimilar approval pathways: comparing the roles of five medicines regulators.

J Law Biosci

September 2024

Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA.

Biologics are playing an increasingly important role in health care globally but are placing a substantial burden on payers. The development of biosimilars-drugs that are highly similar to and have no clinically meaningful differences from originator biologics-is critical to improving the affordability and accessibility of these medications. Medicines regulators, however, have had varied success with biosimilars to date.

View Article and Find Full Text PDF

Extensive social media use and frequency of current e-cigarette use among US youth.

Drug Alcohol Depend Rep

September 2024

Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.

Introduction: Both electronic cigarette (e-cigarette) and social media use among youth are public health concerns. While the health impacts of extensive social media use and frequent use of e-cigarettes have been discussed independently in the literature, little is known about the relationship between the two. This study aims to examine the potential association between extensive social media use and the frequency of current, e-cigarette use among United States (US) youth.

View Article and Find Full Text PDF

Mapping the regulatory landscape for artificial intelligence in health within the European Union.

NPJ Digit Med

August 2024

Department of International Health, Care and Public Health Research Institute (CAPHRI), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.

Regulatory frameworks for artificial intelligence (AI) are needed to mitigate risks while ensuring the ethical, secure, and effective implementation of AI technology in healthcare and population health. In this article, we present a synthesis of 141 binding policies applicable to AI in healthcare and population health in the EU and 10 European countries. The EU AI Act sets the overall regulatory framework for AI, while other legislations set social, health, and human rights standards, address the safety of technologies and the implementation of innovation, and ensure the protection and safe use of data.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with kidney disease are more vulnerable to COVID-19, even after vaccination, compared to those without kidney disease.
  • A study utilized a large Korean COVID-19 registry and NHIS claims data to analyze the risk of infection and severe outcomes among vaccinated and unvaccinated individuals with and without kidney disease.
  • Results indicated that kidney disease patients experienced higher risks of COVID-19 infection and severe health complications post-infection, emphasizing the need for continued vigilance in their care post-vaccination.
View Article and Find Full Text PDF

Background And Aims: Disposable electronic cigarette (e-cigarette) use is becoming more popular among US youth, given the shifting landscape in product marketing, availability and regulation. This study aimed to estimate the prevalence of and test factors associated with the most used e-cigarette product (disposable versus other) among US youth aged 9-18 years who currently use e-cigarettes.

Design, Setting And Participants: This was an observational study using cross-sectional data from the US-based 2021 and 2022 National Youth Tobacco Surveys (n = 48 704).

View Article and Find Full Text PDF

Prevalence of and trends in current cannabis use among US youth and adults, 2013-2022.

Drug Alcohol Depend Rep

September 2024

Department of Communication, College of Arts and Sciences, University of Louisville, Louisville, KY 40292, USA.

Introduction: Cannabis use is increasing due to several factors including the adoption of laws legalizing its use across the United States (US). We examined changes in current cannabis use among US youth and adults and by key sociodemographic groups.

Methods: Using data from the 2013-2022 National Survey on Drug Use and Health (n=543,195), we estimated the prevalence of (2013-2019, 2020, 2021-2022) and trends in (2013-2019, 2021-2022) current (i.

View Article and Find Full Text PDF

Four Decades of Orphan Drugs and Priorities for the Future.

N Engl J Med

July 2024

From the Center for Health Law Studies, Saint Louis University School of Law, St. Louis (M.S.S.); Harvard Business School and the Harvard-MIT Center for Regulatory Science - both in Boston (A.D.S.); Hasso Plattner Institute, University of Potsdam, Potsdam, Germany (A.D.S.); and Duke Law School and the Duke-Margolis Center for Health Policy, Durham, NC (A.K.R.).

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted in Japan to assess the risk of neutropenia (low neutrophil count) in psoriasis patients treated with anti-IL-23 antibodies compared to other treatments.
  • Researchers analyzed data from 1,309 patients who were prescribed various biologic treatments between 2009 and 2021.
  • The findings indicated that anti-IL-23 antibodies did not show a significant increase in neutropenia risk compared to anti-IL-17 antibodies, adalimumab, or apremilast.
View Article and Find Full Text PDF

Background: Cancer patients have an increased risk of cardiovascular outcomes and are susceptible to coronavirus disease 2019 (COVID-19) infection. We aimed to assess the cardiovascular safety of COVID-19 vaccination for cancer patients in South Korea.

Methods: We conducted a self-controlled case series study using the K-COV-N cohort (2018-2021).

View Article and Find Full Text PDF

DifferentialRegulation: a Bayesian hierarchical approach to identify differentially regulated genes.

Biostatistics

October 2024

Department of Molecular Life Sciences and SIB Swiss Institute of Bioinformatics, University of Zurich, Winterthurerstrasse 190, Zurich, 8057, Switzerland.

Although transcriptomics data is typically used to analyze mature spliced mRNA, recent attention has focused on jointly investigating spliced and unspliced (or precursor-) mRNA, which can be used to study gene regulation and changes in gene expression production. Nonetheless, most methods for spliced/unspliced inference (such as RNA velocity tools) focus on individual samples, and rarely allow comparisons between groups of samples (e.g.

View Article and Find Full Text PDF